|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-31
|
$1,889,710
|
$283,457
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Xenograft-like rejection of tumors in a-gal glycolipids
|
5R01CA122019-02
|
$337,188
|
$168,594
|
GALILI, URI
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Xenobiotic-Metabolizing Enzymes
|
ZIA BC 005562
|
$679,493
|
$101,924
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Wwox and Fhit loss and the DNA damage response in breast cancer subtypes
|
2R01CA120516-04
|
$177,099
|
$177,099
|
HUEBNER, KAY
|
OHIO STATE UNIVERSITY
|
|
WUMC Cancer and Leukemia Group B
|
2U10CA077440-12
|
$345,040
|
$141,466
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Wound Response Genes in Cancer Progression
|
5R01CA118750-03
|
$297,782
|
$297,782
|
CHANG, HOWARD
|
STANFORD UNIVERSITY
|
|
Wnt5a and TGF-beta in mammary development and cancer
|
1R01CA126942-01A2
|
$300,875
|
$300,875
|
Serra, Rosa
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Wnt10b's Functional Role on Mammary Stem Cells
|
1K22CA137168-01A1
|
$187,920
|
$187,920
|
MIRANDA-CARBONI, GUSTAVO
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Wnt co-receptor LRP6 turnover and cancer
|
3R01CA124531-02S1
|
$76,322
|
$76,322
|
LI, YONGHE
|
SOUTHERN RESEARCH INSTITUTE
|
|
Wnt co-receptor LRP6 turnover and cancer
|
5R01CA124531-02
|
$375,888
|
$375,888
|
LI, YONGHE
|
SOUTHERN RESEARCH INSTITUTE
|
|
Wnt Antagonist Gene Hypermethylation in Circulating DNA: Cancer Biomarker
|
ZIA BC 011050
|
$55,899
|
$5,590
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
WISER Sister
|
5R01CA131333-02
|
$650,992
|
$650,992
|
SCHMITZ, KATHRYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Whole Genome Association Study of Mammographic Density
|
1R01CA131332-01A2
|
$459,193
|
$459,193
|
TAMIMI, RULLA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Who Cares For Older Breast Cancer Surivors And How Does It Affect Quality?
|
5R01CA127617-02
|
$649,884
|
$649,884
|
Mandelblatt, Jeanne
|
GEORGETOWN UNIVERSITY
|
|
Waveguide-based Biosensor for the Sensitive Detection of Breast Cancer Markers
|
5R03CA132185-02
|
$111,980
|
$111,980
|
Mukundan, Harshini
|
LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB
|
|
Washington University Molecular Imaging Center
|
5P50CA094056-09
|
$1,961,166
|
$98,058
|
PIWNICA-WORMS, David
|
WASHINGTON UNIVERSITY
|
|
Walking Forward - American Indian Participation in Cancer Clinical Trials
|
1U54CA142157-01
|
$1,325,000
|
$450,500
|
PETEREIT, DANIEL
|
RAPID CITY REGIONAL HOSPITAL
|
|
Vitamin D, Related Genes and Breast Cancer Risk
|
2R01CA098661-06A2
|
$1,014,801
|
$1,014,801
|
ZELENIUCH-JACQUOTTE, ANNE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
VITamin D and omegA-3 triaL (VITAL)
|
1U01CA138962-01
|
$2,694,337
|
$538,867
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
VITAMIN D AND MAMMARY GLAND
|
5R01CA069700-16
|
$274,730
|
$274,730
|
Welsh, JoEllen
|
STATE UNIVERSITY OF NEW YORK AT ALBANY
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-26
|
$430,954
|
$168,072
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010183-00580
|
$94,490
|
$4,724
|
McGlynn
|
DCEG (NCI)
|
|
Vermont Breast Cancer Surveillance System
|
3U01CA070013-15S1
|
$83,035
|
$83,035
|
GELLER, BERTA
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
Vermont Breast Cancer Surveillance System
|
5U01CA070013-15
|
$394,832
|
$394,832
|
GELLER, BERTA
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
VEGI-192 As An Anticancer Therapeutic Agent
|
5R01CA113875-04
|
$228,476
|
$57,119
|
LI, LUYUAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
VEGF mRNA Expression Mechanisms in Hypoxia
|
5R01CA064436-13
|
$271,728
|
$271,728
|
CLAFFEY, KEVIN
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
VCU Minority-Based CCOP
|
3U10CA052784-19S1
|
$99,999
|
$40,000
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based CCOP
|
5U10CA052784-19
|
$314,164
|
$125,666
|
Roberts, John
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vault Polymer Conjugates as Multi-Functional Nano Delivery Agents of Cancer Drugs
|
1R21CA137506-01A1
|
$174,000
|
$174,000
|
MAYNARD, HEATHER
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Vanderbilt In Vivo Cellular and Molecular Imaging Center
|
5P50CA128323-02
|
$1,500,000
|
$150,000
|
GORE, JOHN
|
VANDERBILT UNIVERSITY
|
|
VALIDATION AND QUANTIFICATION OF FFPE ANTIGEN RETRIEVAL BY PROTEOME ANALYSIS
|
5R42CA122715-04
|
$750,000
|
$375,000
|
SAXENA, SATYA
|
CALIBRANT BIOSYSTEMS, INC.
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$283,437
|
$28,344
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$330,677
|
$66,135
|
Hodge, James
|
CCR (NCI)
|
|
UWCCC National Cooperative Drug Discovery Group for Can*
|
5U19CA113297-05
|
$1,038,617
|
$259,654
|
SHEN, BEN
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-36S1
|
$59,955
|
$20,984
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-36
|
$4,736,061
|
$1,657,621
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UTPA - Cancer Center at UTHSCSA Border Partnership (2 of 2)
|
5P20CA138021-02
|
$158,445
|
$52,287
|
NAYLOR, SUSAN
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
UTPA - Cancer Center at UTHSCSA Border Partnership (1 of 2)
|
5P20CA138022-02
|
$229,388
|
$75,698
|
BANIK, BIMAL
|
UNIVERSITY OF TEXAS-PAN AMERICAN
|
|
UTMDACC SPORE in Breast Cancer
|
5P50CA116199-05
|
$2,180,817
|
$2,180,817
|
HORTOBAGYI, GABRIEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Utilizing Glycosyltransferases for Bioconjugation
|
ZIA BC 010742
|
$187,047
|
$140,285
|
Qasba, Pradman
|
CCR (NCI)
|
|
Utah Breast Cancer Family Registry
|
5U01CA069446-15
|
$194,477
|
$194,477
|
BUYS, SAUNDRA
|
UNIVERSITY OF UTAH
|
|
UT Southwestern Small Animal Imaging Resource
|
5U24CA126608-03
|
$451,375
|
$90,275
|
MASON, RALPH
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-21
|
$2,091,787
|
$522,947
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Using Technology to Enhance Cancer Communication and Improve Clinical Outcomes
|
5P50CA095817-07
|
$1,716,134
|
$1,132,648
|
GUSTAFSON, DAVID
|
UNIVERSITY OF WISCONSIN MADISON
|
|
USING TECHNOLOGY TO CONNECT RARELY AND NEVER SCREENED WOMEN TO MAMMOGRAPHY
|
1R03CA142102-01
|
$76,000
|
$76,000
|
Alcaraz, Kassandra
|
WASHINGTON UNIVERSITY
|
|
Using Physiological Age to Predict Chemotherapy Toxicity
|
5R01CA124924-03
|
$582,693
|
$582,693
|
Mandelblatt, Jeanne
|
GEORGETOWN UNIVERSITY
|
|
Using New Optical Techniques to Study Cell Signaling in 3D Matrices
|
5R21CA126635-02
|
$176,400
|
$176,400
|
KEELY, PATRICIA
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Using Markov Decision Processes to Optimize Breast Biopsy Decision Making
|
5R21CA129393-02
|
$153,320
|
$153,320
|
Alagoz, Oguzhan
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Using Isolated Cell-Specific Peptides to Improve Cancer Immunotherapy
|
1F31CA134186-01A1
|
$28,191
|
$28,191
|
Diaz, Tracy
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
Use of Mouse Gene Expression Profiles to Predict Human Breast Cancer Prognosis
|
ZIA BC 010909
|
$41,066
|
$41,066
|
Mushinski, J. Frederic
|
CCR (NCI)
|
Total relevant funding to Breast for this search: $599,519,190
|